Lori J. Braender
2023
In 2023, Lori J. Braender earned a total compensation of $1.2M as Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary at Aquestive Therapeutics, a 28% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $263,942 |
|---|---|
| Salary | $417,300 |
| Stock Awards | $480,750 |
| Other | $31,973 |
| Total | $1,193,965 |
Braender received $480.8K in stock awards, accounting for 40% of the total pay in 2023.
Braender also received $263.9K in non-equity incentive plan, $417.3K in salary and $32K in other compensation.
Rankings
In 2023, Lori J. Braender's compensation ranked 1,016th out of 2,983 executives tracked by ExecPay. In other words, Braender earned more than 65.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,016 out of 2,983 | 66th |
Division Manufacturing | 606 out of 1,637 | 63rd |
Major group Chemicals And Allied Products | 416 out of 906 | 54th |
Industry group Drugs | 405 out of 869 | 53rd |
Industry Pharmaceutical Preparations | 278 out of 627 | 56th |
Source: SEC filing on April 26, 2024.
Braender's colleagues
We found two more compensation records of executives who worked with Lori J. Braender at Aquestive Therapeutics in 2023.